African Grey with Progressive Feather Loss and Immunosuppression

Thank you all for bringing this interesting, albeit concerning, case to the table. Given the classic presentation in an African Grey – progressive feather dystrophy, specifically the complete absence of powder down, and the recurrent respiratory infections – my primary differential diagnosis is Psittacine Beak and Feather Disease, or PBFD. The feather changes are highly indicative of circoviral infection affecting the follicular cells. Polyomavirus also warrants consideration, as it can cause feather abnormalities and immunosuppression, though the powder down loss is more typical of PBFD.

My immediate diagnostic plan would involve specific PCR testing. I'd recommend a PBFD PCR and a Polyomavirus PCR from both feather follicles (plucked dystrophic feathers with intact quills) and a whole blood sample. A cloacal swab could also be included for a broader diagnostic yield, particularly if we suspect other enteric pathogens contributing to immunosuppression. Concurrently, a complete blood count and biochemistry panel are crucial to assess the bird's overall health, look for signs of inflammation or immunosuppression (e.g., leukopenia, monocytosis, or a heterophilia with a left shift indicating a severe infection), and evaluate organ function, especially hepatic and renal values. We often see profound immunosuppression in PBFD-affected birds, leading to opportunistic infections, which explains the recurrent respiratory issues.

For supportive care, I'd first ensure the bird is in a warm, low-stress environment with adequate humidity. Nutrition is paramount; if not already on a high-quality pelleted diet, a conversion should be initiated. I’d supplement with a high-quality avian multivitamin containing Vitamin A, such as Nekton-S or Avian Plus, 1 scoop per 100mL drinking water daily, as hypovitaminosis A can exacerbate respiratory issues and poor feather quality. Given the respiratory signs, I would initiate empirical broad-spectrum antibiotic therapy while awaiting culture and sensitivity results from choanal and cloacal swabs. My preference would be doxycycline at 50 mg/kg orally BID, or enrofloxacin at 15 mg/kg orally BID, as these penetrate respiratory tissues well. If severe dyspnea is present, nebulization with sterile saline and an antibiotic like gentamicin (10 mg/mL) or an antifungal like amphotericin B (0.25 mg/mL) could be considered. Prognosis for PBFD in African Greys is guarded to poor, particularly with severe feather dystrophy and recurrent infections. Owners must be counselled on the highly contagious nature and biosecurity risks.

Thank you, Lena, for laying out such a comprehensive diagnostic and initial treatment plan. I entirely agree that PBFD should be at the very top of our differential list here, given the species and pathognomonic feather changes. From a zoo and population health perspective, a confirmed PBFD diagnosis carries significant implications, not just for this individual bird but for any other psittacines in the household or facility, and potentially even for the breeder if this bird originated from a larger collection. This case highlights the critical need for pre-purchase health screening and strict quarantine protocols.

My approach would build on your suggested PCR testing, Lena. I'd particularly emphasize obtaining good quality feather samples – ensuring they are actively growing, not just shed feathers, as the virus replicates in actively dividing cells. A negative PCR on quiescent feathers can be a false negative. Also, a positive blood PCR in the absence of clinical signs indicates an infected but perhaps temporarily asymptomatic bird or an abortive infection. In this case, with overt clinical signs, a positive feather or blood PCR would be highly significant. Given the recurrent respiratory issues and the immunosuppressed state, I'd also strongly advocate for a bacterial culture and antifungal culture from choanal and cloacal swabs, and ideally a tracheal wash or air sac aspirate if the bird's condition allows for it, to accurately guide antimicrobial therapy. Using empiric antibiotics like doxycycline or enrofloxacin is appropriate for stabilization, but we must aim for targeted treatment to avoid further dysbiosis in an already compromised bird.

Additionally, from a preventative and environmental standpoint, I’d investigate the bird’s husbandry meticulously. What is the lighting like? Is there full-spectrum UV-B available? What is the diet's exact composition beyond just 'pelleted'? What about enrichment? Stress and suboptimal husbandry can exacerbate immunosuppression. For immune support, in addition to good nutrition, I often utilize beta-glucans like Avian Biotech's Immunostimulant at 1-2 mg/kg orally once daily, or probiotics. While Lena appropriately mentioned the poor prognosis for African Greys with PBFD, I also counsel owners on the grave ethical decision if they have other birds, as PBFD is highly contagious and environmentally persistent. We must prioritize preventing spread to other avian companions. I might even suggest advanced imaging like a CT scan if the respiratory signs persist or are localized, to rule out granulomas from opportunistic fungal infections like aspergillosis, which is unfortunately common in immunosuppressed African Greys.

Thanks, Rafael and Lena. You both have thoroughly covered the diagnostic and long-term management aspects, and I concur that PBFD is our leading suspect, presenting a severe long-term challenge. However, my immediate concern for this African Grey is its current clinical stability, especially considering the two recent bouts of respiratory infection. This bird is clearly immunosuppressed and actively battling illness. While we await those definitive PCR results, my priority is aggressive supportive care to prevent further deterioration and manage the acute respiratory compromise.

First, I'd perform a rapid but thorough physical exam to assess respiratory effort, hydration status, and body condition. Any signs of dyspnea – tail bobbing, open-mouth breathing, or audible clicking – necessitate immediate oxygen therapy within an incubator, aiming for a 40-60% FiO2. I'd then focus on rehydration. Subcutaneous fluids are a good start if the bird is mildly dehydrated (Lactated Ringer's Solution at 50-75 mL/kg divided into multiple sites daily), but if severe dehydration or shock is suspected, intraosseous (IO) or intravenous (IV) fluid therapy is critical. I'd place an IO catheter into the distal ulna or proximal tibiotarsus and start a warmed crystalloid (e.g., LRS or Normosol-R) bolus at 10 mL/kg over 15-20 minutes, followed by a maintenance rate of 50-75 mL/kg/day. We need to prevent cardiovascular collapse.

Nutritional support is also paramount. Anorexia is common, and cachexia will severely hinder recovery. If the bird isn't eating independently, I would initiate assisted feeding via a flexible rubber feeding tube directly into the crop (e.g., Harrison's Recovery Formula or Critical Care Formula at 15-20 mL/kg body weight, 2-3 times daily). We need to provide calories and essential nutrients. Regarding the ongoing respiratory infection, while C&S are ideal, I wouldn't hesitate to initiate broad-spectrum antimicrobial therapy empirically, immediately. Given the severity, I might opt for a combination of injectable antibiotics to ensure rapid systemic levels. Ceftazidime (20-40 mg/kg IM BID) is an excellent choice for gram-negative coverage, and I might add a potent anti-fungal like voriconazole (10-15 mg/kg PO BID, loading dose 20 mg/kg PO once) to cover for opportunistic aspergillosis, which is a significant threat in immunosuppressed African Greys, especially with respiratory signs. Nebulization, as Lena mentioned, is also an excellent adjunct therapy. My main difference might be the urgency and aggressiveness of initiating these life-saving interventions before all diagnostic results are in, to give the bird the best chance of surviving the acute crisis while we await confirmation of the underlying PBFD.